Ameritas Investment Partners, Inc. Bristol Myers Squibb CO Transaction History

Ameritas Investment Partners, Inc.

  • $2.98 Billion
  • Q4 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 62,260 shares of BMY stock, worth $3.42 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
62,260
Previous 51,961 19.82%
Holding current value
$3.42 Million
Previous $2.69 Million 30.99%
% of portfolio
0.12%
Previous 0.09%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$51.92 - $59.94 $534,724 - $617,322
10,299 Added 19.82%
62,260 $3.52 Million
Q3 2024

Nov 13, 2024
SELL
$39.66 - $51.75 $133,852 - $174,656
-3,375 Reduced 6.1%
51,961 $2.69 Million
Q2 2024

Aug 13, 2024
BUY
$40.25 - $52.99 $13,604 - $17,910
338 Added 0.61%
55,336 $2.3 Million
Q1 2024

May 13, 2024
SELL
$47.98 - $54.4 $13,818 - $15,667
-288 Reduced 0.52%
54,998 $2.98 Million
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $183,060 - $218,441
-3,776 Reduced 6.39%
55,286 $2.84 Million
Q3 2023

Nov 13, 2023
SELL
$57.89 - $64.73 $301,259 - $336,854
-5,204 Reduced 8.1%
59,062 $3.43 Million
Q2 2023

Aug 11, 2023
SELL
$63.71 - $70.74 $299,564 - $332,619
-4,702 Reduced 6.82%
64,266 $4.11 Million
Q1 2023

May 10, 2023
BUY
$65.71 - $74.53 $20,501 - $23,253
312 Added 0.45%
68,968 $4.78 Million
Q4 2022

Feb 13, 2023
SELL
$68.48 - $81.09 $78,272 - $92,685
-1,143 Reduced 1.64%
68,656 $4.94 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $19 - $11,295
147 Added 0.21%
69,799 $4.96 Million
Q2 2022

Aug 12, 2022
SELL
$72.62 - $79.98 $119,677 - $131,807
-1,648 Reduced 2.31%
69,652 $5.36 Million
Q1 2022

May 13, 2022
SELL
$61.48 - $73.72 $76,173 - $91,339
-1,239 Reduced 1.71%
71,300 $5.21 Million
Q4 2021

Feb 11, 2022
SELL
$53.63 - $62.52 $54,059 - $63,020
-1,008 Reduced 1.37%
72,539 $4.52 Million
Q3 2021

Nov 15, 2021
SELL
$59.17 - $69.31 $35,028 - $41,031
-592 Reduced 0.8%
73,547 $4.35 Million
Q2 2021

Aug 06, 2021
SELL
$61.91 - $67.42 $69,834 - $76,049
-1,128 Reduced 1.5%
74,139 $4.95 Million
Q1 2021

May 14, 2021
SELL
$59.34 - $66.74 $85,746 - $96,439
-1,445 Reduced 1.88%
75,267 $4.72 Million
Q4 2020

Feb 12, 2021
SELL
$57.74 - $65.43 $134,765 - $152,713
-2,334 Reduced 2.95%
76,712 $4.76 Million
Q3 2020

Nov 13, 2020
SELL
$57.43 - $63.64 $140,129 - $155,281
-2,440 Reduced 2.99%
79,046 $4.77 Million
Q2 2020

Aug 05, 2020
SELL
$54.82 - $64.09 $82,065 - $95,942
-1,497 Reduced 1.8%
81,486 $4.79 Million
Q1 2020

May 13, 2020
BUY
$46.4 - $67.43 $47,188 - $68,576
1,017 Added 1.24%
82,983 $4.63 Million
Q4 2019

Feb 13, 2020
BUY
$49.21 - $64.19 $710,936 - $927,352
14,447 Added 21.4%
81,966 $5.26 Million
Q3 2019

Nov 14, 2019
SELL
$42.77 - $50.71 $27,116 - $32,150
-634 Reduced 0.93%
67,519 $3.42 Million
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $35,071 - $38,781
-786 Reduced 1.14%
68,153 $3.09 Million
Q1 2019

May 15, 2019
SELL
$45.12 - $53.8 $68,898 - $82,152
-1,527 Reduced 2.17%
68,939 $3.29 Million
Q4 2018

Feb 12, 2019
SELL
$48.76 - $63.23 $29,987 - $38,886
-615 Reduced 0.87%
70,466 $3.66 Million
Q3 2018

Nov 13, 2018
SELL
$55.19 - $62.25 $103,315 - $116,532
-1,872 Reduced 2.57%
71,081 $4.41 Million
Q2 2018

Aug 13, 2018
SELL
$50.53 - $62.98 $170,892 - $212,998
-3,382 Reduced 4.43%
72,953 $4.04 Million
Q1 2018

May 15, 2018
SELL
$59.92 - $68.98 $681,649 - $784,716
-11,376 Reduced 12.97%
76,335 $4.83 Million
Q4 2017

Feb 14, 2018
SELL
$59.94 - $65.35 $138,401 - $150,893
-2,309 Reduced 2.56%
87,711 $6.66 Million
Q3 2017

Nov 15, 2017
SELL
$55.23 - $63.74 $91,074 - $105,107
-1,649 Reduced 1.8%
90,020 $5.61 Million
Q2 2017

Aug 15, 2017
BUY
N/A
91,669
91,669 $5.11 Million

Others Institutions Holding BMY

# of Institutions
2,749
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $117B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email